Search Within

Sergio Andres Giralt

  1. "2019"
Formats
  1. Meeting Abstract (72)
  2. Journal Article (18)
  3. Review (4)
  4. Guidelines (2)
  5. Research Letter (1)
Groups
  1. Bone Marrow Transplant (97)
  2. Center for Hematologic Malignancies (97)
  3. Department of Medicine (97)
  4. Hematologic Malignancies, Division of (97)
  5. Survivorship Research (70)
  6. CTCR Scholars (60)

More Groups

People
  1. Miguel-Angel Perales (50)
  2. Molly Maloy (49)
  3. Gunjan Shah (37)
  4. Michael Scordo (34)
  5. Parastoo Dahi (32)
  6. Sean Devlin (32)

More People

Years
  1. 2019 (97)
Publications
  1. Biology of Blood and Marrow Transplantation (37)
  2. Blood (23)
  3. Bone Marrow Transplantation (7)
  4. Clinical Lymphoma, Myeloma and Leukemia (7)
  5. Journal of Clinical Oncology (3)
  6. Blood Advances (2)

More Publications

Publishers
  1. Elsevier Inc. (44)
  2. American Society of Hematology (25)
  3. Nature Publishing Group (9)
  4. American Society of Clinical Oncology (3)
  5. Elsevier Science, Inc. (3)
  6. Taylor & Francis Group (3)

More Publishers

Results (97)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Allogeneic stem cell transplantation (alloHSCT) for chronic lymphocytic leukemia (CLL) in the era of novel agents
    Meeting Abstract

    Roeker, L. E.; Brown, J. R.; Dreger, P.; Lahoud, O. B.; Eyre, T. A.; Brander, D. M.; Skarbnik, A.; Coombs, C. C.; Kim, H. T.; Manchini, S. T.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Difference in involved and uninvolved free light chain (dFLC) of less than 1mg/DL early post risk adapted melphalan and autologous stem cell transplantation (RA-ASCT) predicts renal response at 1 year in light chain (AL) amyloidosis
    Meeting Abstract

    Purvey, S.; Seier, K.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Hassoun, H.; Giralt, S. A.; Landau, H. J.
    Blood (2019)

    Fulltext@MSK | Save
  • Comparing gradings of immune effector cells toxicities: Application of ASTCT consensus grading system and implications for clinical management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Maloy, M. A.; Devlin, S. M.; Batlevi, C. L.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • An observational, retrospective analysis of retreatment with carfilzomib in the management of patients with multiple myeloma
    Meeting Abstract

    Peterson, T. J.; Korde, N.; Hassoun, H.; Mailankody, S.; Lesokhin, A. M.; Hultcrantz, M.; Shah, U. A.; Smith, E. L.; Lu, S. X.; Landau, H. J.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • EASIX and modified-EASIX are early predictors of severe cytokine release syndrome and neurotoxicity in patients treated with chimeric antigen receptor T cells
    Meeting Abstract

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J.; Maloy, M. A.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Batlevi, C. L.; Brentjens, R. J.; Devlin, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Cognitive impairment is associated with inferior survival and increased non-relapse mortality in older allogeneic hematopoietic cell transplant (alloHCT) recipients: A multicenter retrospective study
    Meeting Abstract

    Olin, R. L.; Fretham, C.; Pasquini, M. C.; Arora, M.; Bhatt, V. R.; Derman, B.; Giralt, S. A.; Huang, L. W.; Koll, T. T.; Lee, S. M.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Dynamic easix scores closely predict non-relapse mortality after allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Nawas, M. T.; Sanchez-Escamilla, M.; Devlin, S. M.; Maloy, M. A.; Giralt, S. A.; Perales, M. A.; Scordo, M.
    Blood (2019)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in combination with multi-morbidity and functional impairment
    Meeting Abstract

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Elko, T. A.; Ruiz, J. D.; Sauter, C. S.; Dahi, P. B.; Maloy, M. A.; Perales, M. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T cell therapy in vulnerable older patients with relapsed/refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, J. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Long-term sustained minimal residual disease (MRD) negativity in multiple myeloma patients treated with lenalidomide maintenance therapy: A clinical and correlative phase 2 study
    Meeting Abstract

    Landgren, O.; Mastey, D.; Lesokhin, A. M.; Smith, E. L.; Shah, U. A.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Salcedo, M.; more...
    Blood (2019)

    Fulltext@MSK | Save